Embla Medical hf: Conference call details for Q1 2025 - Börskollen
Börskollen - Aktier, fonder och ekonominyheter

Börskollen

För dig med koll på börsen

Pressmeddelande

Embla Medical hf: Conference call details for Q1 2025

Reykjavik, Iceland/Copenhagen, Denmark, 1 April, 2025. Embla Medical (Nasdaq Copenhagen: EMBLA) will publish its Q1 2025 Report on 29 April 2025 at 7:00 CET. A conference call will be hosted on the same day at 9:00 CET / 7:00 GMT / 3:00am EST.

The event will be hosted by Sveinn Solvason, President and CEO, and G. Arna Sveinsdottir, CFO. The call will include a review of the quarterly results and will be held in English.

Slides used in the presentation will be made available on the company website at the following link: https://www.emblamedical.com/investors

To participate in the telephone conference, please use the dial-in details provided below:

DK: +45 78 76 84 90

SE: +46 31-311 50 03

UK: +44 20 3769 6819

US: +1 646 787 0157

Participant access code: 274982

The webcast will be available through following link:  Embla Medical Q1 2025 webcast

Financial calendar and events 2025

29 April 2025                 Interim report Q1 2025

29 April 2025                 Q1 2025 HCA Capital virtual presentation and Q&A

29 April 2025                 Q1 2025 Road Show Copenhagen (Carnegie)

30 April 2025                 Q1 2025 Road Show Frankfurt (Carnegie)

5 May 2025                    Q1 2025 Virtual Road Show US (Danske Bank)

6 May 2025                    Q1 2025 Virtual Road Show UK (DNB)

7 May 2025                    Q1 2025 Road Show Helsinki (Nordea)

8 May 2025                    Redeye MedTech Day, Stockholm

19 May 2025                  AktieInfo Investor Event (Retail), Copenhagen

3 June 2025                   Carnegie Healthcare Day, Paris

22 July 2025                  Interim report Q2 2025

27 Aug 2025                  Økonomisk Ugebrev Life Science Conference, Copenhagen

4 Sept 2025                   Goldman Sachs MedTech conference, London

16 Sept 2025                 Pareto Securities Annual Healthcare Conference, Stockholm

18 Sept 2025                  HC Andersen Investor Seminar, Copenhagen

21 Oct 2025                    Interim Report Q3 2025

25 Nov 2025                   Nordea Focus Seminar, Paris

26 Nov 2025                  Danske Bank Winter Seminar, Copenhagen

If you wish to receive Embla Medical press releases by e-mail, please register here

For further information please contact

Klaus Sindahl

Head of Investor Relations

M: +45 5363 0134

E: [email protected]

About Embla Medical

Embla Medical (Nasdaq Copenhagen: EMBLA) is a leading global provider of innovative mobility solutions that help people live a Life Without Limitations®. Home to several leading brands, Embla Medical is dedicated to improving people‘s mobility by providing prosthetics, neuro orthotics, bracing & supports and patient care through a global network of orthotic & prosthetic facilities. Embla Medical is committed to sustainable business practices renowned for positively impacting people‘s health and well-being.

Bifogade filer

20250401 EMBLA PR Q1 2025 Conf Call invitationhttps://mb.cision.com/Main/18404/4128474/3358371.pdf

Nyheter om Embla Medical

Läses av andra just nu

Om aktien Embla Medical

Senaste nytt